Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...
InvestorsHub on MSN
Lantern Pharma to Spotlight AI Drug-Development Platforms at UNT’s First AI4BM Symposium
Lantern Pharma Inc. (NASDAQ:LTRN) is set to showcase two of its commercially deployed artificial intelligence platforms at the University of North Texas’ inaugural AI for Biology and Medicine (AI4BM) ...
Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...
Pharmaceutical Technology on MSN
Abzena and Mabqi partner for drug development solution
"Abzena and Mabqi partner for drug development solution" was originally created and published by Pharmaceutical Technology, a ...
The wide range of chromatographic techniques share one common aim: to separate a material into its components. A material, your sample, is dissolved in a solvent, called the mobile phase. This mixture ...
With an AI-led platform for drug discovery and a growing global client base, Medvolt AI is emerging as one of India’s most ...
Discover how DAOs revolutionize drug discovery through decentralized funding, transparency, and community governance.
Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...
Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...
A stylized image of Max Barnhart sitting on a chair with his arm on a pillow, receiving an IV infusion. The background is a grid containing a microscope image of malaria parasites flanked on each side ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results